FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

FRA:FRE • DE0005785604

50.9 EUR
-0.42 (-0.82%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 32 industry peers in the Health Care Providers & Services industry. FRE has an average financial health and profitability rating. FRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • FRE had positive earnings in the past year.
  • In the past year FRE had a positive cash flow from operations.
  • Of the past 5 years FRE 4 years were profitable.
  • Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • FRE has a Return On Assets (2.69%) which is in line with its industry peers.
  • FRE's Return On Equity of 6.14% is in line compared to the rest of the industry. FRE outperforms 46.88% of its industry peers.
  • The Return On Invested Capital of FRE (3.26%) is worse than 71.88% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for FRE is significantly below the industry average of 6.99%.
  • The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • FRE's Profit Margin of 5.11% is amongst the best of the industry. FRE outperforms 87.50% of its industry peers.
  • In the last couple of years the Profit Margin of FRE has declined.
  • Looking at the Operating Margin, with a value of 9.76%, FRE belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • FRE's Operating Margin has declined in the last couple of years.
  • FRE's Gross Margin of 24.99% is in line compared to the rest of the industry. FRE outperforms 53.13% of its industry peers.
  • In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
  • FRE has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, FRE has more shares outstanding
  • Compared to 1 year ago, FRE has an improved debt to assets ratio.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.11 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FRE has a Altman-Z score (2.11) which is comparable to the rest of the industry.
  • FRE has a debt to FCF ratio of 11.17. This is a negative value and a sign of low solvency as FRE would need 11.17 years to pay back of all of its debts.
  • FRE has a Debt to FCF ratio of 11.17. This is comparable to the rest of the industry: FRE outperforms 40.63% of its industry peers.
  • FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating FRE is somewhat dependend on debt financing.
  • FRE's Debt to Equity ratio of 0.61 is amongst the best of the industry. FRE outperforms 84.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.11
ROIC/WACC0.6
WACC5.42%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • FRE has a Current ratio of 1.26. This is in the better half of the industry: FRE outperforms 65.63% of its industry peers.
  • FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FRE's Quick ratio of 0.99 is fine compared to the rest of the industry. FRE outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

  • The earnings per share for FRE have decreased by -6.72% in the last year.
  • Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
  • FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.64%.
  • The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)-6.72%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-71.7%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.63%

3.2 Future

  • Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.27% on average per year.
  • FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.51% yearly.
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.27%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.51%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.11 indicates a rather expensive valuation of FRE.
  • FRE's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, FRE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 13.31, which indicates a correct valuation of FRE.
  • Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than 71.88% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. FRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.11
Fwd PE 13.31
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 71.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.91
EV/EBITDA 10.93
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.31
PEG (5Y)N/A
EPS Next 2Y12.74%
EPS Next 3Y11.84%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.98%, FRE has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.65, FRE pays a bit more dividend than its industry peers.
  • FRE's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

  • 59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (2/27/2026, 7:00:00 PM)

50.9

-0.42 (-0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.67B
Revenue(TTM)21.83B
Net Income(TTM)1.14B
Analysts85.22
Price Target56.38 (10.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.75%
PT rev (3m)2.85%
EPS NQ rev (1m)2.29%
EPS NQ rev (3m)1.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 18.11
Fwd PE 13.31
P/S 1.28
P/FCF 23.91
P/OCF 13.17
P/B 1.54
P/tB 15.48
EV/EBITDA 10.93
EPS(TTM)2.81
EY5.52%
EPS(NY)3.83
Fwd EY7.52%
FCF(TTM)2.13
FCFY4.18%
OCF(TTM)3.87
OCFY7.59%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.31
PEG (5Y)N/A
Graham Number45.72
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.11
F-Score7
WACC5.42%
ROIC/WACC0.6
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.72%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-71.7%
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.27%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.63%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.51%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.77%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 3 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Overvalued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 13.8% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.